结核性硬化综合体的罕见表现:低度瘤细胞瘤和扩散性脂质瘤
Astrid Kolind Christensen1, Louise Schmidt Iversen2, Lise Graversen3
1Urology, Aarhus University Hospital, Aarhus, Denmark.
BMJ case reports
|July 18, 2025
概括
结核性硬化综合体 (TSC) 是一种罕见的遗传疾病. 本病例报告详细介绍了罕见的TSC表现,包括扩散性脂质瘤和低度瘤瘤,强调了不同的临床表现.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 结核性硬化综合体 (TSC) 是一种罕见的遗传疾病,由TSC1或TSC2基因的致病变体引起.
- TSC的特点是各种器官的良性瘤的发展.
- 在TSC的表型变异性可以导致诊断挑战.
研究的目的:
- 报告一个罕见的结核性硬化综合体 (TSC) 病例,表现异常.
- 突出与罕见的TSC呈现相关的诊断和管理挑战.
- 强调全面的诊断技术和跨学科的关怀在TSC的重要性.
主要方法:
- 一个20多岁的男性患者的病例报告,有脏瘤和扩散性脂质瘤病史.
- 审查患者的病史,包括许多活检和成像研究.
- 基因检测用于识别TSC1或TSC2基因中的致病变体.
主要成果:
- 这位患者出现了脏瘤,最初被误诊为染色恐惧性细胞癌和腿部扩散性脂质瘤.
- 瘤最终被诊断为低度瘤细胞瘤 (LOT),这是一个新认可的实体.
- 确定了一种TSC1致病变体,证实了TSC的诊断.
结论:
- 这一案例强调了TSC显著的表型多样性,包括罕见的表现,如扩散性脂质和LOT.
- 准确的诊断和有效的TSC管理需要全面的诊断方法和多学科的合作.
- 早期和精确的诊断对于适当的治疗策略至关重要,例如用于TSC相关瘤的everolimus治疗.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Pulmonary Tuberculosis III
448
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
448
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


